P-218

N/A

Report date: 2024/06/03 20:00:36
NME

Base Information

Drug NameP-218
Drug Alias NameP-218
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDihydrofolate reductase inhibitors
TargetsDihydrofolate reductase
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMedicines for Malaria Venture
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedicines for Malaria Venture
Active IndicationsN/A
Inactive IndicationsMalaria

Other Information

ATC CodeN/A
Related LinksN/A